Skin Toxicity
Conditions
Brief summary
Our study aims to clarify the impact of the use of a standard sunbed according to new EU guideline EN 60335-2-27 and possibly discount the positive effects of tanning beds. We plan to investigate the serum elevation of 25(OH)D under sunbed use, respecting the new recommendations for the exposure plan for different skin types according to EN 60335-2-27. The use of a sunbed will be compared to a control group not using a sunbed in the observation period. * Trial with medical device
Detailed description
We will compare to baseline changes in serum vitamin D and health-related quality of life using a control group and an intervention group.
Interventions
DEVICEsunbed exposure
exposure to sunbed ultraviolet radiation
Sponsors
University of Zurich
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Probands intending to use a commercial sunbed : 1. Age 18 years or older 2. Regular use of commercial sunbeds 3. Oral and written informed consent
Exclusion criteria
1. Skin type I according to Fitzpatrick according to EU guideline EN 60335-2-27 2. Sunbed use within the last three months 3. Use of vitamin D supplements or multivitamin supplements 4. Any medical condition which renders them unfit for sunbed use in the judgment of the investigator 5. Inability to provide oral and written consent to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of number of patients with a relevant elevation of serum 25-hydroxyvitamin D levels of =10ug/L from the baseline | six months |
Countries
Switzerland
Outcome results
None listed